We like to highlight people that are doing interesting work in our industry, and this week we want to put the spotlight on Tracy Harmon Blumenfeld.
We had a chance to catch up with Julian Jenkins to talk about the opportunities and risks for mHealth tools in clinical trials.
I was recently asked what is preventing a rapid transition to risk-based monitoring. While the relative newness of the process is often blamed for the slow rate of adoption, I believe that psychological factors based on misperceptions—including the fear of the unknown—may be the primary reason.
I recently read an article in Smart Data Collective about trial optimization (or “trail optimization,” as they called it in an unfortunate typo!) It's a good summary of some of the discussions at a recent industry conference and there is a theme that runs through it, summed up by the following quotes: